ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,263Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 69

$1.07M Total Retail Price of All Prescriptions

Rank: 2 out of 69

640 Patients Receiving at Least One Drug in Part D
25%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

69% of this provider’s 640 patients filled at least one prescription for a schedule two drug, compared to an average of 49%.

Schedule Three
Controlled Substances

58% of this provider’s 640 patients filled at least one prescription for a schedule three drug, compared to an average of 43%.

Risky Drugs to Seniors

12% of this provider’s 3,373 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 15%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 3,058 794 S3 1 1
CARISOPRODOL 1,075 171 R 2 11
OXYCODONE HCL-ACETAMINOPHEN 993 226 S2 3 5
MORPHINE SULFATE ER 892 165 S2 4 4
METHADONE HCL 807 112 S2 5 10
GABAPENTIN 742 183 6 2
ZOLPIDEM TARTRATE 656 173 7 13
OXYCODONE HCL 586 130 S2 8 3
MORPHINE SULFATE 485 61 S2 9 22
FENTANYL 462 142 S2 10 6
TRAMADOL HCL 452 128 11 9
PROMETHAZINE HCL 424 34 R 12 20
TIZANIDINE HCL 386 41 13 7
BACLOFEN 377 95 14 18
MELOXICAM 355 59 15 14
ENDOCET 330 63 S2 16 8
CYCLOBENZAPRINE HCL 262 37 R 17 12
LYRICA 221 48 18 15
HYDROXYZINE HCL 174 37 R 19 41
METHOCARBAMOL 160 40 R 20 21
OXYCODONE-ACETAMINOPHEN 159 31 S2 21 17
LIDODERM 146 30 22 23
AMITRIPTYLINE HCL 137 50 R 23 25
LUNESTA 132 28 24 48
PRAMIPEXOLE DIHYDROCHLORIDE 115 19 25 51
TOPIRAMATE 109 11 26 26
NEXIUM 107 0 27 42
TRAZODONE HCL 107 0 27 29
KADIAN 97 23 S2 10 29 54
OXYCONTIN 93 16 S2 30 16
MEPERIDINE HCL 90 20 S2 R 10 31 57
CYMBALTA 82 15 32 19
SUMATRIPTAN SUCCINATE 76 0 33 59
CHLORZOXAZONE 76 18 R 33 47
CELEBREX 73 12 35 31
OPANA ER 72 0 S2 36 28
BUSPIRONE HCL 66 0 37 46
VOLTAREN 66 16 37 27
IBUPROFEN 64 17 39 36
OXYMORPHONE HCL 62 13 S2 40 64
DESIPRAMINE HCL 53 0 41 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.